InvestorsHub Logo
Followers 165
Posts 19766
Boards Moderated 2
Alias Born 12/09/2004

Re: lt2211 post# 166099

Wednesday, 09/19/2018 5:44:53 PM

Wednesday, September 19, 2018 5:44:53 PM

Post# of 461993
This is the P2 Tox study out of Australia. It was originally a 52 (?) week study that has been extended at the request of the subjects and their care givers. Efficacy was a secondary end point of the trial which had no placebo.

What was shown today is the title of the presentation. The data of the 19 subjects still in the trial is what will be presented.


If investing was easy, everyone would be rich by now.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News